Background Although endovenous stents have been associated with overall low morbidity,
they can require reinterventions to correct stent malfunction due to in-stent restenosis (ISR) …

Cilostazol, a phosphodiesterase III inhibitor, has vasodilating and antiplatelet properties with
a low rate of bleeding complications. It has been used over the past 25 years for improving …

Background and aim In-stent restenosis (ISR) belongs to an infrequent but potentially
serious complication after carotid angioplasty and stenting in patients with severe carotid …

Carotid artery stenting (CAS) is less invasive and has a lower incidence of systemic
complications such as myocardial infarction compared with carotid endarterectomy …

Objective Optimal platelet inhibition is an important therapeutic adjunct in patients with
carotid artery stenosis undergoing carotid artery stenting (CAS). Clopidogrel resistance is …

Purpose: To examine whether carotid artery stenting (CAS) of stenoses with unstable plaque
using a closed-cell stent-in-stent technique prevents plaque protrusion. Materials and …

Purpose: To evaluate the effect of cilostazol on major outcomes after carotid artery stenting
(CAS). Methods: A systematic literature review was conducted conforming to established …

Antiplatelet agents are essential for the successful management of patients undergoing a
variety of neurointerventional procedures. The most commonly used anti-platelet agents are …

Background and purpose CT angiography (CTA) is an increasingly used method for
evaluation of stented vessel segments. Our aim was to compare the appearance of different …

In-stent stenosis is a feared complication of flow diversion treatment for cerebral aneurysms.
We present 2 cases of patients treated with pipeline flow diversion for unruptured cerebral …